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Harlequin ichthyosis (HI) is the most severe and frequently lethal form of recessive congenital ichthyosis. Although
defects in lipid transport, protein phosphatase activity, and differentiation have been described, the genetic basis
underlying the clinical and cellular phenotypes of HI has yet to be determined. By use of single-nucleotide–poly-
morphism chip technology and homozygosity mapping, a common region of homozygosity was observed in five
patients with HI in the chromosomal region 2q35. Sequencing of the ABCA12 gene, which maps within the minimal
region defined by homozygosity mapping, revealed disease-associated mutations, including large intragenic deletions
and frameshift deletions in 11 of the 12 screened individuals with HI. Since HI epidermis displays abnormal lamellar
granule formation, ABCA12 may play a critical role in the formation of lamellar granules and the discharge of
lipids into the intercellular spaces, which would explain the epidermal barrier defect seen in this disorder. This
finding paves the way for early prenatal diagnosis. In addition, functional studies of ABCA12 will lead to a better
understanding of epidermal differentiation and barrier formation.
Introduction
Harlequin ichthyosis (HI [MIM 242500]) is a very severe
and usually lethal skin disorder of unknown cause (Hsu
et al. 1989; Moreau et al. 1999; Sarkar et al. 2000). HI
is also known as “harlequin fetus” because of the ten-
dency for affected babies to be born prematurely. The
neonate is covered in a thick “coat of armor” that se-
verely restricts movement (Hsu et al. 1989; Dahlstrom
et al. 1995; Sarkar et al. 2000). The skin dries out to
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form hard diamond-shaped plaques separated by fissures,
resembling “armor plating.” The normal facial features
are severely affected, with distortion of the lips (ecla-
bion), eyelids (ectropion), ears, and nostrils. Historically,
an HI-affected neonate would usually die within 2 d of
birth because of feeding problems, bacterial infection,
and/or respiratory distress. However, a number of pa-
tients have survived because of the wider availability of
neonatal intensive care and likely benefits from oral reti-
noids (Hsu et al. 1989; Moreau et al. 1999; Elias et al.
2000; Sarkar et al. 2000). In survivors, the disease comes
to resemble severe nonbullous congenital ichthyosiform
erythroderma (NBCIE) (Haftek et al. 1996; Choate et al.
1998). The skin barrier remains severely compromised,
which leads to increased transepidermal water loss, im-
paired thermal regulation, and increased risk of second-
ary infection (Moskowitz et al. 2004).
HI occurs in both sexes and in many ethnic groups.
Autosomal recessive (AR) inheritance of HI has been
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Figure 1 Typical clinical presentation of HI at birth
inferred, but, in a large number of cases, the inheritance
pattern cannot be ascertained, and the disorder could be
due to a new dominant mutation. It has been subdivided
into three types based on the expression of keratin 16
and profilaggrin and the appearance of keratohyalin
granules (Dale et al. 1990). Studies have also reported
abnormalities in the localization of epidermal lipids and
have highlighted the abnormal ultrastructure of epider-
mal lamellar granules in HI that are associated with the
absence of extracellular lamellar structures in all three
subtypes (Dale et al. 1990; Akiyama et al. 1996, 1997,
1998). The nuclei of the keratinocytes also show abnor-
malities, since they appear to become flattened early on
in differentiation (in the lower cell layers), but some are
retained even as the cornified layer is sloughed off. This
parakeratosis along with hyperkeratosis and hyper-
granulosis (retention of keratohyalin granules in the
stratum granulosum) is a characteristic phenotype of the
epidermis of neonates with HI (Buxman et al. 1979;
Hsu et al. 1989). This may suggest that the process of
terminal differentiation is not completed in HI-affected
skin. Alterations in calcium-mediated signaling and pro-
tein phosphatase activity have also been reported in HI
keratinocytes (Kam et al. 1997; Michel et al. 1999).
Plausible candidate genes underlying these diverse cel-
lular phenotypes in HI have included filaggrin, claudins,
PP2A, and calpain 1 (Kam et al. 1997; Michel et al.
1999).
Mutations in the genes encoding transglutaminase-1
(TGM1 [MIM 190195]), ichthyin, 4 lipoxygenase 3
(ALOXE3 [MIM 607206]), and 12(R)-lipoxygenase
(ALOX12B [MIM 603741]) have all been shown to
underlie both NBCIE and lamellar ichthyosis (LI) (Hu-
ber et al. 1995; Jobard et al. 2002; Lefevre et al. 2004).
Recently, missense mutations in the gene encoding the
adenosine triphosphate (ATP)-binding cassette (ABC
[GenBank accession number NM_173076]) transporter
protein ABCA12 (MIM 607800) have also been shown
to cause LI (Lefevre et al. 2003). Unlike the other AR
forms of ichthyosis, the genetic basis of HI has not been
elucidated.
In the present study, we have used SNP-array tech-
nology to localize the HI gene, on the basis of the prin-
ciple of homozygosity mapping. This identified a major
locus for HI on chromosome 2q35 and subsequent dis-
ruptive mutations in the ABCA12 gene in 11 of the 12
analyzed patients with HI. Most of the mutations iden-
tified would result in a severely truncated protein. This
genetic study immediately establishes the means for early
prenatal DNA diagnosis of HI and provides a molecular
clue toward understanding the numerous biological ab-
normalities of epidermal differentiation in HI-affected
skin.
Material and Methods
Clinical
Twelve families, from diverse ethnic backgrounds, with
individuals affected with HI were included in the present
genetic study—three from the United States, seven from
Great Britain, and two from Italy. Ethical approval was
obtained from the local research ethics committees. The
clinical phenotype was verified as HI by at least two
clinicians; the typical clinical presentation at birth is
shown in figure 1. A summary of the clinical details is
shown in table 1. The control population was of mixed
ethnicity and consisted of 60 unrelated individuals.
SNP-Array Analysis
A SNP GeneChip Mapping 10K (Affymetrix) array an-
alysis was performed on affected individuals from six
families. Two of these families were consanguineous,
with AR inheritance of HI. Patient DNA samples were
processed in accordance with the standard GeneChip
Mapping 10K Xba Assay protocol. Briefly, 350 ng of
DNA was digested with XbaI and ligation to the XbaI
adaptor prior to PCR amplification by use of AmpliTaq
Gold with Buffer II (Applied Biosystems). For each DNA
sample, four 100-ml PCRs were set up to obtain sufficient
purified PCR product (20 mg), by use of Ultrafree-MC
filtration column (Millipore), for subsequent fragmenta-
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tion with DNase I. Fragmentation was visualized by 4%
agarose-gel electrophoresis to confirm the production of
50–100-bp PCR fragments prior to 3′ labeling with bio-
tin and hybridization to the SNP array. Hybridized ar-
rays were processed with an Affymetrix Fluidics Station
450, and fluorescence signals were detected using the
Affymetrix GeneChip Scanner 3000. Raw SNP call data
were exported to Microsoft Excel for analysis. The av-
erage call rate (expressed as a percentage)  SEM for
the six patients was .97.62% 0.41%
Microsatellite and Linkage Analysis
Data from SNP chips revealed an overlapping region
of homozygosity, in five of the six affected individuals,
at a position on chromosome 2. Microsatellite markers
mapping to this region were used to confirm and refine
the minimal region of homozygosity. DNA from patient
blood samples was first amplified with the microsatellite
markers D2S325 (chromosome 2q33.3) and D2S126
(chromosome 2q36.1) from the Applied Biosystems Link-
age Mapping Set. Sample DNA was amplified with these
primers at 5 mM for 30 cycles at 55C, by use of Ampli-
taq Gold PCR Mastermix (Applied Biosystems). D2S128
(chromosome 2q34) and D2S1345 (chromosome 2q34)
were selected from the University of California–Santa
Cruz (UCSC) Genome Bioinformatics database, and PCR
was performed using Bioline Biotaq DNA Polymerase,
Bioline PCR buffer, 60 nM MgCl2, and 20 pM of each
primer, with a final reaction volume of 20 ml. Fluores-
cent-tagged PCR products were analyzed using the ABI
3700 capillary sequencer. Haplotypes were constructed
from the microsatellite data of affected individuals and
unaffected siblings. Linkage analysis was performed us-
ing the Genehunter program (Kruglyak et al. 1996).
Sequence Analysis of ABCA12
Primer design and PCR conditions were the same as
those described elsewhere (Lefevre et al. 2003), with the
exception that a 15-ml reaction volume was used. The
PCR products covering each of the 53 exons and re-
spective intron boundaries were purified using ExoSAP-
IT (Amersham Pharmacia Biotech) and were sequenced
on either the forward or reverse strand, by use of ABI
BigDye Terminator reagents (Applied Biosystems) and an
ABI 3700 sequencer (sequencing reaction conditions: 5
ml of purified product, 1 ml of BigDye Terminator v.1.1,
3 ml of Better Buffer [Microzone], 1 ml water; annealing
temperature of 60C). Sequence analysis was performed
using Phred, Phrap, and Consed, and variants were de-
tected using reference sequences taken from the Ensembl
Genome Browser (Ewing and Green 1998; Ewing et al.
1998; Gordon et al. 1998). Likely disease-associated mu-
tations were screened in a total of 120 control chromo-
somes—either by direct sequencing or by RFLP analysis
if the mutation altered a restriction site.
Results
Genetic Mapping
From the SNP-array analysis, only one region of the
genome, 2q35, was found to have large blocks of homo-
zygosity in common for five of the six affected individ-
uals assessed by means of this methodology (fig. 2). This
common interval was calculated to be a genetic distance
of ∼1.5 Mb. To support linkage of HI to 2q35, micro-
satellite markers that map to this region were identified
using the UCSC Genome Browser. The microsatellite ge-
notype data are consistent with a recessive mode of in-
heritance of HI and linkage of the disease gene to 2q35
in the largest consanguineous family with HI (fig. 3A).
Linkage analysis was performed for this family, but the
size of the family prohibited the calculation of a statis-
tically significant LOD score (data not shown). This high-
lights the usefulness of the SNP array for homozygosity
mapping in diseases not applicable to classic genetic link-
age studies. Affected individuals from families in which
the mode of inheritance is unknown were also genotyped
with these microsatellite markers. Of the 12 affected
individuals analyzed in the present study, 11 were homo-
zygous for one or more of the markers analyzed in the
2q35 region (fig. 3B).
Candidate-Gene Analysis
Six genes were identifiable, from the UCSC Genome
Browser, that map within the minimal region, including
BARD1, which interacts with the breast-ovarian cancer–
associated protein BRCA1; ATIC, in which mutations
are the cause of a purine biosynthesis disorder (AICA-
ribosuria [MIM 608688]); Fibronectin 1, which is in-
volved in cell adhesion and migration; the FLJ10116
gene, which encodes a protein of unknown biological
function; and the PECR gene, which encodes a peroxi-
somal trans 2-enoyl CoA reductase. The gene ABCA12,
which encodes the ABC transporter protein, also maps
within the minimal homozygous region on chromosome
2q35. Missense mutations in this gene have recently been
shown to underlie the less severe ichthyotic disorders LI
and NBCIE (Lefevre et al. 2003). Since the transport of
extracellular epidermal lipids is abnormal in HI (Dale et
al. 1990) and a defect in epidermal lipid metabolism has
been suggested in the pathogenesis of the disease (Bux-
man et al. 1979), ABCA12 could be a plausible candi-
date gene on the basis of chromosome position and func-
tion. The 53 coding exons of the ABCA12 gene were
individually amplified by PCR and were sequenced for
12 patients. Mutations in ABCA12 were detected in 11
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Figure 2 Localization of the HI gene to chromosome 2q35 by use of SNP-array mapping. A, Homozygous SNP profiles of chromosome
2 in six patients with HI. Black bars indicate homozygous SNP call data. Blue bars indicate the minimal common region of homozygous SNPs
in patients 1–5, a genetic distance of ∼1.5 Mb. B, Ideogram of chromosome 2 showing the position of ABCA12 (red bar), located within the
minimal common region of homozygous SNPs (blue) identified in panel A. C, The genetic interval of the homozygous SNP “blocks” in each
patient with HI, with clear indication that the ABCA12 gene maps within the common homozygous region for five of the six patients.
of the 12 patients (fig. 4). This indicates that ABCA12
mutations are a major genetic cause of HI. The majority
of the mutations were predicted to result in a truncated
protein; indeed, in one patient (40), the last 25 exons
were homozygously deleted. Four patients all harbored
the same homozygous frameshift mutation and, on the
basis of haplotype analysis (see fig. 3B) and their shared
ethnicity, it is likely to be the same founder mutation in
at least three of the four patients. In individual 955–01,
a homozygous missense substitution (W198C) in exon
6 was identified in addition to the more disruptive ho-
mozygous nonsense substitution in exon 44. The latter
sequence change is more likely to be associated with HI.
Unlike the other individuals with HI in the mutation
study who were homozygous for a specific ABCA12 mu-
tation, individual 44 was a compound heterozygote for
two different ABCA12 mutations. Both SNP and micro-
satellite genotypes were heterozygous in the chromo-
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Figure 3 Analysis of microsatellite markers flanking the ABCA12 gene. A, Segregation of microsatellite markers flanking ABCA12 at
chromosome 2q35 in a family with HI. Only affected individual 6 is homozygous at this region of chromosome 2. Note that the majority of
siblings with HI are deceased. B, Haplotype analysis of individuals with HI. Microsatellite markers map around the ABCA12 gene locus (215,
621, 772–215, 828, 657) at chromosome 2q35. Several patients are homozygous for the markers D2S325 (208, 096, 142–208, 096, 490),
D2S128 (214, 917, 811–214, 918, 065), D2S1345 (214, 991, 103–214, 991, 425), and D2S126 (221, 842, 419–221, 842, 782). The genome
positions (Mb) for ABCA12 and microsatellite markers on chromosome 2 are shown in parentheses.
somal region harboring the ABCA12 locus in this pa-
tient. In only one patient (50) with HI was there no
ABCA12 mutation detected. None of the mutations were
detected in the control population.
Discussion
The ABC superfamily is a large family of transmembrane
proteins involved in transport of substrates across both
the plasma membrane and intracellular membranes. Mu-
tations in ABC genes cause diverse diseases, including
cystic fibrosis, X-linked adrenoleukodystrophy, Tangier
disease, pseudoxanthoma elasticum, and Dubin-Johnson
syndrome (Stefkova et al. 2004). In the present article,
we report, we believe for the first time, that mutations
in the ABCA12 gene, a member of the ABCA subfamily,
cause HI. Genetic studies of this disorder have been ham-
pered by the fact that families with more than one af-
fected child are rare. Families with only one affected
individual are unsuitable for genetic linkage studies be-
Figure 4 Mutation analysis of the ABCA12 gene in patients with HI. A, Table summarizing mutation analysis. An asterisk (*) indicates
a sequence change to a stop codon. B, i, Chromatogram showing homozygous GC deletion in exon 42 of patient 7. ii, Chromatogram showing
homozygous TrC substitution in exon 44 in patient 955-01. iii, Chromatogram showing heterozygous A deletion in exon 33 of patient 44.
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cause of (1) the difficulties in determining whether the
disease has been inherited in an AR mode or is due to a
new dominant mutation and (2) the low statistical power
for linkage analysis. An additional complicating factor
is the possibility of genetic heterogeneity.
The results of the Affymetrix 10K SNP-array genome
scan of five unrelated patients with HI showed sugges-
tive linkage to a region on chromosome 2q35 on the
basis of having a large homozygous SNP haplotype
“block” in common, a genetic distance of ∼1.5 Mb.
Microsatellite markers from this region were identified
from the UCSC Genome Browser, and subsequent ge-
notypes were consistent with a locus for HI on 2q35
on the basis of homozygosity at that locus in 11 of the
12 patients with HI described in this study. The ABCA12
gene encoding an ABC transporter protein that is pos-
tulated to be involved in the transport of epidermal
lipids is localized within the chromosomal region en-
compassed by these microsatellite markers. This was
regarded as an excellent candidate gene to underlie the
HI phenotype, since abnormal or absent epidermal lip-
ids in HI skin have been described. Mutation analysis
revealed that 11 of the 12 analyzed patients with HI
had a disease-associated mutation in the ABCA12 gene.
The majority of the mutations were predicted to lead
to a severely truncated protein, with the exception of a
missense substitution and a splice-site mutation. In con-
trast, the ABCA12 mutations in LI/NCBIE were all mis-
sense and were restricted to within the ATP-binding
domain of the protein. Thus, the mutations in HI are
likely to disrupt other aspects of ABCA12 function and
may provide the molecular reason behind the severity
of HI compared with the milder skin conditions LI and
NCBIE. Further mutation studies are in progress to
identify the molecular spectra of mutations in a larger
panel of patients with HI, including those subcatego-
rized into the different types of HI (Dale et al. 1990).
The data in the present article reveal that ABCA12 mu-
tations are the major cause of HI.
In normal epidermis, the cytoplasm of cells of the
upper spinous and granular cell layers contain small
granules, 100–300 nm in size, known as “Odland bod-
ies” (Odland 1960); lamellar granules; lamellar bodies;
or membrane-coating granules. These move toward the
cell membrane as they enter the granular cell layer. They
discharge their lipid components and proteases into the
intercellular space and play important roles in barrier
function, desquamation, and intercellular cohesion with-
in the stratum corneum (Menon et al. 1992; Elias et al.
2000). Lipid delivery to lamellar bodies has also been
shown to be required for subsequent delivery of protein
to the organelle (Rassner et al. 1999). The defect in
ABCA12 in HI may explain the observed abnormalities
in the lamellar granules, possibly associated with se-
verely compromised skin-barrier function. This is analo-
gous to the situation in lung in which surfactant is stored
in lamellar bodies in alveolar type II cells. Mutations in
ABCA3 cause fatal surfactant deficiency in newborns,
with markedly abnormal lamellar bodies observed ultra-
structurally (Shulenin et al. 2004). The lamellar bodies
in epidermis also contain beta-defensin, a microbicidal
peptide that is also found in the intercellular space,
which suggests that it might be discharged with lipid
components of the lamellar body (Oren et al. 2003).
The defect in epidermal barrier and the loss of beta-
defensin may also result in increased susceptibility to
infection. Additionally, mutations in two other genes of
the ABCA family cause disorders of lipid transport. The
ABCA1 gene is mutated in Tangier disease and in the
less severe, heterozygous, familial hypoalphalipoprotein-
emia as well as in premature atherosclerosis, the resul-
tant disorder dependent on the site of the mutation
(Brooks-Wilson et al. 1999; Rust et al. 1999; Clee et
al. 2000). The ABCA4 gene is mutated in patients with
Stargardt disease, in some patients with AR retinitis pig-
mentosa, and in patients with AR cone-rod dystrophy
(Stefkova et al. 2004). Our observation that mutations
in the ABCA12 gene cause HI is analogous to other
systemic disorders of lipid transport. In addition, like
ABCA1 and ABCA4, the site and type of mutation in
the ABCA12 gene determine the severity of the condi-
tion, with the more disruptive genetic lesions, such as
deletion or frameshift mutations, causing HI.
Prenatal screening tests for HI historically involved
invasive procedures, such as fetoscopically and ultra-
sonographically guided fetal-skin biopsies that reveal key
ultrastructural features, such as multivesicular lamellar
granules in affected fetuses at 20–24 wk of gestation
(Elias et al. 1980; Suzumori and Kanzaki 1991). Similar
morphological changes have been described in amniotic
fluid cells at 17 wk of gestation (Akiyama et al. 1994).
Other methods that have been used in recent years for
the prenatal diagnosis of HI are three-dimensional
and four-dimensional real-time sonography (Vohra et
al. 2003). A major translational benefit of our present
findings is that DNA-based analysis should now be pos-
sible, which paves the way for earlier (i.e., first trimester)
prenatal testing that is more reliable and conclusive than
the other non-DNA–based prenatal screening techniques.
In summary, we have applied the rapid SNP-array ge-
notyping technology to identify, by homozygosity map-
ping, ABCA12 mutations as the major underlying ge-
netic cause of the devastating skin disease HI. Pre-
viously, this disease had proved difficult to map by clas-
sic linkage analysis because of the limited size of pedi-
grees. The association of ABCA12 mutations with HI
will facilitate prenatal DNA diagnosis of this life-threat-
ening disorder as well as the possibility of preimplan-
tation genetic testing. In addition, results of the present
study suggest a major role for ABCA12 in lipid trans-
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port, barrier formation, and keratinocyte differentia-
tion. The increased understanding of the biological role
of ABCA12 in HI may lead to the development of tar-
geted therapy to lessen the burden of this disease for
both surviving children with HI and their parents.
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